Advertisement
Advertisement

VTGN

VTGN logo

Vistagen Therapeutics, Inc. Common Stock

0.57
USD
Sponsored
+0.01
+2.12%
Jun 04, 10:22 UTC -4
Open

VTGN Earnings Reports

Positive Surprise Ratio

VTGN beat 20 of 38 last estimates.

53%

Next Report

Date of Next Report
Jun 15, 2026
Estimate for Q4 26 (Revenue/ EPS)
$273.02K
/
-$0.34
Implied change from Q3 26 (Revenue/ EPS)
-9.89%
/
-24.44%
Implied change from Q4 25 (Revenue/ EPS)
+1720.15%
/
-20.93%

Vistagen Therapeutics, Inc. Common Stock earnings per share and revenue

On Feb 12, 2026, VTGN reported earnings of -0.45 USD per share (EPS) for Q3 26, beating the estimate of -0.49 USD, resulting in a 9.22% surprise. Revenue reached 303.00 thousand, compared to an expected 373.32 thousand, with a -18.84% difference. The market reacted with a -7.23% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 7 analysts forecast an EPS of -0.34 USD, with revenue projected to reach 273.02 thousand USD, implying an decrease of -24.44% EPS, and decrease of -9.89% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Greenwich LifeSciences, Inc.
Report Date
Jun 01, 2026 For Q4 25
Estimate
-$0.32
Actual
-$0.57
Surprise
-77.70%
logo
Connect Biopharma Holdings Limited Ordinary Shares
Report Date
May 22, 2026 For Q1 26
Estimate
-$1.53
Actual
-$2.35
Surprise
-53.05%
FAQ
For Q3 2026, Vistagen Therapeutics, Inc. Common Stock reported EPS of -$0.45, beating estimates by 9.22%, and revenue of $303.00K, -18.84% below expectations.
The stock price moved down -7.23%, changed from $0.55 before the earnings release to $0.51 the day after.
The next earning report is scheduled for Jun 15, 2026.
Based on 7 analysts, Vistagen Therapeutics, Inc. Common Stock is expected to report EPS of -$0.34 and revenue of $273.02K for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement